References
- Widmer AF. New developments in diagnosis and treatment of infection in orthopaedic implants. Clin Infect Dis 2001; 33: 94–106
- Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422–9
- Zimmerli W, Trampuz A, Ochsner P. Prosthetic joint infections. N Engl J Med 2004; 351: 1645–54
- Hanssen AD, Spranghel MJ. Treatment of the infected hip replacement. Clin Ortop 2004; 420: 63–71
- Berbari EF, Marculescu C, Sia I, Lahr BD, Hanssen AD, Steckelberg JM, et al. Culture-negative prosthetic joint infection. Clin Infect Dis 2007; 45: 1113–9
- Betsch BY, Eggli S, Siebenrock KA, Täuber MG, Mühleman K. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis 2008; 46: 1221–69
- Brandt CM, Sistrunk WW, Duffy MC. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24: 914–9
- Tattevin P, Cremieux AC, Pottier P, Huten D, Carbon C. Prosthetic joint infection: when can prosthesis salvage be considered?. Clin Infect Dis 1999; 29: 292–5
- Aboltins CA, Page MA, Buising KL, Jenney AW, Daffy JR, Choong PF, Stanley PA. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin Microbiol Infect 2007; 13: 586–91
- Soriano A, García S, Bori G, Almela M, Gallart X, Macule F, et al. Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 2006; 12: 930–3
- Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, Osmond DR. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006; 42: 471–8
- Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for the treatment of orthopaedic implant-related staphylococcal infections: a randomized controlled trial. Foreign body infection group. JAMA 1998; 279: 1537–14
- Berberàn J, Aguilar L, Carroquino G, Gimenez MJ, Sanchez B, Martinez D, Prieto J. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 2006; 119: 9937–99310
- Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, Osmon DR. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998; 27: 1247–54
- Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81
- NHI Consensus Development Panel on total hip replacement. NHI consensus conference: total hip replacement. JAMA 1995;273:1950–6.
- Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect 2008; 70: 3–10
- Managram, AJ, Horan, TC, Pearson, ML, Silver, LC, Jarvis, WR, Hospital Infection Control Practice Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999;20:247–78.
- Meehan AM, Osmond DR, Duffy MCT, Hanssen AD, Keating MR. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis 2003; 36: 845–9
- Atkins BL, Athanasou N, Deeks JJ, Crook DW, Sompson H, Peto TE, et al. Prospective evaluation criteria for microbiological diagnosis of prosthetic joint infections at revision arthroplasty. The ORISIS Study Group. J Clin Microbiol 1998; 36: 2932–9
- Müller M, Morawietz L, Hasard O, Strube P, Perka C, Tothz S. Diagnosis of periprosthetic infection following total hip arthroplasty: evaluation of the diagnostic value of pre- and intra-operative parameters and the associated strategy to preoperatively selected patients with a high probability of joint infection. J Orthop Surg Res 2008; 3: 31
- Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs 2006; 66: 1089–105